These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors. Mennel HD; Lell B Clin Neuropathol; 2005; 24(1):13-8. PubMed ID: 15696779 [TBL] [Abstract][Full Text] [Related]
44. Expression of L1 cell adhesion molecule is a significant prognostic factor in pT3-stage gastric cancer. Kodera Y; Nakanishi H; Ito S; Misawa K; Ito Y; Nakayama G; Koike M; Fujiwara M; Yamamura Y; Nakao A Anticancer Res; 2009 Oct; 29(10):4033-9. PubMed ID: 19846947 [TBL] [Abstract][Full Text] [Related]
45. Genetic aberrations in gliomatosis cerebri. Ware ML; Hirose Y; Scheithauer BW; Yeh RF; Mayo MC; Smith JS; Chang S; Cha S; Tihan T; Feuerstein BG Neurosurgery; 2007 Jan; 60(1):150-8; discussion 158. PubMed ID: 17228264 [TBL] [Abstract][Full Text] [Related]
46. Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis. Cummings TJ; Hulette CM; Longee DC; Bottom KS; McLendon RE; Chu CT Clin Neuropathol; 1999; 18(4):190-7. PubMed ID: 10442461 [TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas. Tuccari G; Giuffrè G; Crisafulli C; Barresi G Eur J Histochem; 1999; 43(4):317-22. PubMed ID: 10682270 [TBL] [Abstract][Full Text] [Related]
48. Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression. Wilhelmsson U; Eliasson C; Bjerkvig R; Pekny M Oncogene; 2003 May; 22(22):3407-11. PubMed ID: 12776191 [TBL] [Abstract][Full Text] [Related]
49. [Diffuse cerebral gliomatosis. Clinical, nuclear magnetic resonance tomography and pathologic findings]. Neuhold A; Brainin M; Jellinger K Nervenarzt; 1989 Jul; 60(7):437-40. PubMed ID: 2548102 [No Abstract] [Full Text] [Related]
50. Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendroglioma. Luider TM; Kros JM; Sillevis Smitt PA; van den Bent MJ; Vecht CJ Electrophoresis; 1999; 20(4-5):1087-91. PubMed ID: 10344289 [TBL] [Abstract][Full Text] [Related]
51. Leptomeningeal dissemination of malignant glioma: immunohistochemical analysis of tenascin and glial fibrillary acidic protein. Higuchi M; Arita N; Ohnishi T; Hiraga S; Kusakabe M; Sakakura T; Hayakawa T Clin Neuropathol; 1995; 14(4):223-7. PubMed ID: 8521626 [TBL] [Abstract][Full Text] [Related]
52. Characterization of two new permanent glioma cell lines 8-MG-BA and 42-MG-BA. Perzelová A; Máciková I; Mráz P; Bízik I; Steno J Neoplasma; 1998; 45(1):25-9. PubMed ID: 9604998 [TBL] [Abstract][Full Text] [Related]
53. Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance. Gómez M; Hernández ML; Pazos MR; Tolón RM; Romero J; Fernández-Ruiz J Neuroscience; 2008 May; 153(3):687-99. PubMed ID: 18400407 [TBL] [Abstract][Full Text] [Related]
55. In vitro heterogeneity in human gliomas. Are all transformed cells of glial origin? Franks AJ; Burrow HM Anticancer Res; 1986; 6(4):625-9. PubMed ID: 3019220 [TBL] [Abstract][Full Text] [Related]
56. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors. Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861 [TBL] [Abstract][Full Text] [Related]
57. [Interleukin 1 and gliomas: immunohistochemical and immunocytochemical examinations]. Tanaka S; Kamitani H; Hori T; Hirai Y; Nakai S; Kawai K No To Shinkei; 1988 Mar; 40(3):205-10. PubMed ID: 2840106 [TBL] [Abstract][Full Text] [Related]